GlassScriptPhysician profile
Benjamin J Remington
NPI 1679541528
$2,937.74
in general payments reported to CMS, 2019-2025
26 companies · $316 in 2025
The $316 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $913 · 2020: $648 · 2021: $781 · 2022: $92.37 · 2023: $23.57 · 2024: $163 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,139.82 | 2019-2021 | |
| Boston Scientific Corporation | $405.16 | 2019-2025 | Wavewriter Alpha Prime 16, Artisan, Spectra Wavewriter |
| Livanova USA, INC. | $211.01 | 2019-2022 | |
| Integra Lifesciences Corporation | $159.84 | 2020-2021 | |
| Medtronic USA, INC. | $111.59 | 2019-2020 | |
| Abbott Laboratories | $86.71 | 2019-2024 | Eterna |
| Captiva Spine INC | $75.61 | 2019 | |
| Curonix LLC | $72.96 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Depuy Synthes Sales INC. | $72.20 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $63.22 | 2021 | |
| Globus Medical, INC. | $61.77 | 2021 | |
| Medtronic, INC. | $57.25 | 2021 | |
| Baxter Healthcare | $53.87 | 2022 | |
| Orthofix Medical, INC. | $44.89 | 2024 | Meridian, M6-C |
| Osteomed LLC | $43.61 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.31 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $34.31 | 2019-2020 | |
| Intrinsic Therapeutics | $32.43 | 2025 | Barricaid Acd (Annular Closure Device) |
| Relievant Medsystems, INC. | $31.83 | 2021 | |
| Clariance, INC. | $30.80 | 2021 | |
| Si-Bone, INC. | $25.41 | 2019 | |
| Zimmer Biomet Holdings, INC. | $20.84 | 2020 | |
| Arbor Pharmaceuticals, INC. | $19.53 | 2019 | |
| Redhill Biopharma INC. | $18.76 | 2021 | |
| Aesculap, INC. | $14.61 | 2021 | |
| Ceribell, INC. | $9.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Remington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.